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Background Psychological interventions may be beneficial for bipolar disorder. 
Aims Efficacy evaluation of psychological interventions for adults with bipolar disorder. 
Methods A systematic review of randomised controlled trials. Outcomes were meta-analysed 
using RevMan and confidence assessed using the GRADE-method. 
Results We included 55 trials with 6010 participants. Moderate quality evidence associated 
individual psychological interventions with reduced relapses at post-treatment (RR=0.66 [CI: 
0.48 to 0.92]) and follow-up (RR=0.74 [CI: 0.63-0.87]), and collaborative care with a 
reduction in hospitalisations. Low quality evidence associated group interventions with fewer 
depression relapses at post-treatment and follow-up, and family psycho-education with 
reduced symptoms of depression and mania. 
Conclusions There is evidence that psychological interventions are effective for people with 
bipolar disorder. Limits were the very low quality of much of the evidence and therefore 
inconclusive. Further research should identify the most (cost-)effective interventions for each 
phase of this disorder. 








Bipolar disorder affects approximately 1.5% of the population,(1-5) and often takes a chronic 
course with recurrent manic, hypomanic, depressive, and mixed episodes. Bipolar disorder is 
associated with poor psychosocial functioning,(6) a high economic burden,(7-10) and early 
mortality.(11) People with bipolar disorder are symptomatically ill almost half of the 
time.(12) Although mania often results in hospitalisation,(13) depressive symptoms and 
episodes account for most illness-related disability.(1) In trying to manage the illness, people 
with bipolar disorder use pharmacological interventions, but 60% of outpatients that start 
with maintenance treatment will have an episode within two years.(13) As an additional 
strategy, many people with bipolar disorder wish to use psychological interventions to 
improve symptoms and to reduce relapse rates. Previous meta-analyses have evaluated 
evidence for a specific psychological intervention (e.g., cognitive behavioural therapy 
(CBT),(14-18) family interventions,(17, 19) and psychoeducation(17, 18)), some during acute 
episodes and some during euthymic periods, with varying duration of intervention and 
follow-up. The number of relevant trials has tripled since the last meta-analyses, and a current 
review is needed to inform the selection of psychological interventions for each stage of 
bipolar disorder. Given the need for a comprehensive evaluation, we conducted a systematic 
review and meta-analysis of psychological interventions for adults with bipolar disorder 
compared with control groups (treatment-as-usual, waitlist, attention control or an active 
intervention) on symptoms of depression and mania, response, relapse, discontinuation, 
hospitalisation, quality of life, and psychosocial functioning. This review informed the 
National Institute for Health and Clinical Excellence (NICE) guideline on the management of 
bipolar disorder(20) and the Netherlands Psychiatric Association (NVvP) and Trimbos 




We included randomised controlled trials of all individual, group, and family 
psychological interventions for adults (18 years and older). We also included service-level 
intervention with (elements of) psychological interventions (e.g. collaborative care).  Eligible 
comparison groups were control groups (treatment-as-usual, waiting list or attention control) 
or other active interventions. Trials were eligible if at least 66% of the participants had 
bipolar disorder or if disaggregated data were reported for participants with bipolar disorder. 
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For trials also including participants with other mental disorders (e.g. unipolar depression or 
schizophrenia), we requested disaggregated data.  
Search strategy 
We searched CINAHL, Embase, Medline, PreMedline, PsycINFO, CDSR, DARE, HMIC, 
and CENTRAL from inception to January 2014 using terms for bipolar disorder and 
randomised clinical trials (online Appendix 1.1). Searches were not restricted by language. 
MO and RB assessed the eligibility of studies for inclusion and discussed disagreements with 
a third author (EMW). After our search, we searched the reference lists of the included 
studies, excluded studies, and previous reviews. We contacted study authors and experts to 
request additional reports of trials. 
Assessment of bias 
Studies were assessed and rated independently by two authors (MO, PC) using the 
Cochrane Collaboration Risk of Bias Assessment Tool.(23) Disagreements were discussed 
with a third author (EMW) and resolved by consensus. Each study was rated for risk of bias 
owing to sequence generation; allocation concealment; blinding of participants, assessors, 
and providers; selective outcome reporting (e.g., reporting incomplete data or not all of the 
outcomes measured); and incomplete data. Risk of bias for each domain was rated as high 
(seriously weakens confidence in the results), low (unlikely to seriously alter the results), or 
unclear.  
Data management 
Service user outcomes included reduction of symptoms of depression and mania 
(response), relapse (any type, depression, mania or mixed), hospitalisation, quality of life, 
suicide, psychosocial functioning, and study discontinuation. We also extracted treatment 
format, number and length of sessions, method of recruitment, inclusion and exclusion 
criteria, age, sex, setting, study location and number of people with bipolar I disorder. For 
each study, the important study characteristics are reported in the online Appendix 1.2.  
Treatment in the acute phase typically aims at remission of the index episode, and if 
symptoms of the index episode reappear after a short period, the term "relapse" is often used. 
Long-term management aims to prevent future episodes, which are often called 
“recurrence”.(24) In this review, it was impossible to distinguish between “relapse” and 
“recurrence” because studies included both acutely symptomatic and euthymic participants 




Psychological treatments developed for bipolar disorder may differ in the underlying 
therapeutic tradition (e.g. cognitive behaviour therapy, interpersonal therapy, 
psychoeducation) and delivery, but they share non-specific treatment factors (e.g. contact 
with a caring professional, problem-solving, coping with stigma),(25) so their effects may be 
aggregated in meta-analysis to explore the range of potential effects. In this review, 
psychotherapies were aggregated by methods of delivery, including individual treatments, 
group treatment, family therapy, and collaborative care. Information about the effects of 
interventions with different therapeutic traditions were analysed in subgroups.     
For continuous outcomes, we calculated the standardised mean difference (SMD), 
Hedges’s g, for between-group differences. For dichotomous outcomes, we calculated the 
risk ratio (RR) for events. All outcomes are reported with 95% confidence intervals. Overall 
effects were calculated using random effects models. Continuous effects were weighted by 
the inverse of variance; dichotomous effects were weighted using the Mantel-Haenszel 
method.(23)  Because time-to-event data were reported inconsistently, and often incompletely 
(e.g. as curves without associated events or statistics), we were unable to analyse these 
results; however, most studies were short and similar in duration, and hazard ratios would be 
similar to the relative risks reported here. 
Missing data were noted for each outcome. When missing cases were not reported, we 
contacted the authors. If continuous outcomes were reported for completers as well as 
controlling for missing data (for example, imputed using regression methods), we used the 
data that controlled for missing data.  
Statistical heterogeneity was assessed by visual inspection of forest plots, by performing 
the χ2 test (assessing the P value), and by calculating the I2 statistic, which describes the 
percentage of observed heterogeneity that would not be expected by chance. If the P value 
was less than 0.10 and I2 exceeded 50%, we considered heterogeneity to be substantial. Meta-
analyses of comparisons and subgroups were conducted using RevMan 5.2,(26) due to the 
few studies per type of intervention a meta-regression would not be meaningful and is 
therefore not conducted. Confidence in the results was assessed by MO and EMW using the 
GRADE method,(27) which is a structured assessment of the quality of evidence attending to 






Of 13,641 potentially relevant citations and four from other sources, we retrieved 59 
papers, which were assessed for inclusion (Figure 1). Of these, three were excluded because 
only a minority of participants had bipolar disorder and we could not obtain disaggregated 
data, (28-30) and one was a trial of a measurement instrument. (31) Fifty five randomised 
controlled trials were, therefore, included, of which four were unpublished(32-35) at time of 
inclusion, two have recently been published(34, 35) and the other 51 trials were published 
between 1984 and 2014. Seven were not included in the meta-analysis because they did not 
report useable outcomes, which remained unavailable after contacting the authors.(36-42) 
Study characteristics  
Online Appendix 1.2 presents study characteristics for each trial. Included studies 
randomised 6010 participants, ranging from 19 to 441 per study.  Studies were conducted in 
North America (k=22), England and Ireland (k=12), Central Europe (k=11), Australia (k=5), 
Brazil (k=3), and Iran (k=2). Participants were recruited from outpatient (k=23) or inpatient 
settings (k=12), GP practices (k=2), Community Mental Health Teams (k=2), or advertising 
combined with (self) referral (k=16). In 52 studies a diagnostic interview was used to 
establish the presence of bipolar disorder, in one study participants themselves reported if 
they had bipolar disorder, another confirmed the diagnosis through a questionnaire, and one 
study only reported that bipolar disorder was an inclusion criterion. 
Across all trials, the median of the mean age of participants was 40 years (range 26 to 55), 
the median percentage who were female was 58% (range 1% to 77%) and the median 
percentage of participants with bipolar I disorder was 81% (range 42% to 100% and one 
study with 0%).  Four studies included participants experiencing a depressive episode at 
baseline, (43-46) six studies included both participants experiencing depressive and manic 
episodes,(37, 38, 47-50) and 32 studies included only euthymic participants. Twelve 
studies(35, 40, 41, 51-59) included a mix of euthymic and symptomatic participants at 
baseline, of which only two studies(35, 59) provided disaggregated data.  
Interventions 
Trials included a variety of interventions (online Appendix 1.3) and comparison 
conditions and were grouped in nine comparisons. The first five comparisons were 
interventions compared with treatment as usual (individual treatment, group treatment, family 
therapy, collaborative care, integrated cognitive and interpersonal therapy). Four comparisons 




Online Appendix 1.4 lists the continuous measures used in the trials by outcome type. 
Dichotomous data were also reported. Response was determined through clinical interviews 
(e.g. SCID), cut-off points on diverse scales (e.g. when scoring symptomatic at baseline and 
at a follow-up scoring on the YMRS<11 for manic response or Bech–Rafaelsen scores < 6 for 
depression response) or a percentage of reduction on a scale (e.g. 50% on the HAM-D for a 
depression response). In most trials, participants had to score above a cut off score for a 
period of time (e.g. two months) to be considered responsive. Relapse in most cases was 
determined with a clinical interviews, for example with the Structured Clinical Interview for 
DSM (SCID-LIFE), Schedule for Affective Disorders and Schizophrenia (SADS) and the 
Mini-International Neuropsychiatric Interview (M.I.N.I.). Other trials established relapse in 
participants with a score above a cut-off point on a depression (e.g. HAM-D>12) or mania 
scale (e.g. YMRS>20 for mania); in some, a combination of the two scales was used to 
evaluate the presence of mixed episodes. Five studies assumed that a relapse had occurred 
based on chart reviews or hospitalisation records.  
Risk of bias  
Each risk of bias item is presented as percentages across all studies in table 1 and for each 
studied independently in online Appendix 1.5. No trials were at high risk of bias for random 
sequence generation; however, the method of randomisation was not reported in 15 trials. 
Allocation concealment was unclear in 25 trials and low risk in 30 trials. Blinding of 
participants and providers in trials of psychological interventions is impossible, so all were at 
high risk of bias per se. Nine trials only used self-report measures and 32 trials reported blind 
assessor rated outcomes, these 41 trials were at low risk of bias for blinding. However, eight 
studies did not have blinded assessors and these were considered to be at high risk of bias. In 
six studies, it was unclear if assessors were blinded. For incomplete outcome data, 25 trials 
were at low risk of bias and 24 were at high risk of bias because of the number (more than 
10%) of missing cases or because missing cases were excluded from the analyses. In six 
studies, the handling of missing data was not described.  
Reporting bias  
Risk of reporting bias could not be assessed indirectly (e.g., using funnel plots or statistical 
methods) because there were few studies for most comparisons and the studies were of 
similar size. We used direct methods to assess risk of reporting bias by checking trial 
registrations and by contacting authors.  There was a high risk of reporting bias in 22 trials, 
including seven studies that did not report any usable data. In addition to the outcomes we 
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analysed, several trials also reported incomplete results that could not be included in the 
meta-analysis. Only 11 studies were prospectively registered, but 23 others were assessed to 
be at low risk of bias because authors provided missing data or confirmed that all outcomes 
were published.  
Overall quality of the evidence 
Using the GRADE method,(27) many outcomes were downgraded because of risk of bias 
(e.g., inappropriate handling of missing data). Nearly all results were downgraded at least one 
level because of imprecision (the analyses included few participants or events). Results for 
relapse following individual interventions, hospitalisation following collaborative care, and 
study discontinuation during interpersonal and social rhythm therapy were of moderate 
quality. Most other evidence was of low or very low quality. Studies also reported controlled 
comparisons at follow-up, but most outcomes were of very low quality. 
Quantitative data synthesis   
Across nine comparisons, results of the meta-analyses suggest that psychological 
interventions may be associated with symptomatic improvement, and fewer relapses and 
hospitalisations. The majority of these low to moderate quality outcomes are summarized per 
comparison and presented in table 2 (post-treatment) and table 3 (follow-up) with reasons for 
downgrading, for all outcomes per comparison and subgroups we refer to online Appendix 
1.6 and 1.7.  
 
Individual psychological interventions 
The search identified 15 RCTs (n=1580) of face-to-face and interactive online 
psychoeducation(35, 59-64) cognitive (behavioural) therapy(34, 43, 51, 52, 65-68) and 
medication adherence therapy.(69) Interventions were compared with treatment as usual. 
Eleven trials enrolled participants who were euthymic at baseline, four trials enrolled a mix 
of participants experiencing acute episode of mania or depression and participants who were 
euthymic.(35, 51, 52, 59)   
Seven trials (n=637) reported low quality evidence that individual psychological 
interventions were associated with a small reduction in symptoms of depression at post-
treatment.(35, 51, 59, 65-68) Six trials (n=365) reported moderate quality evidence that 
individual psychological interventions reduced the risk of relapse at post-treatment.(51, 64-
66, 68, 69) However, three trials found no difference in effect on symptoms of mania.(65, 67, 
68) One trial with few events was inconclusive regarding the risk of hospitalisation.(69) 
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Eight trials (n=532) reported moderate quality evidence that individual psychological 
interventions were associated with a reduction in relapse at follow-up.(59, 63-66, 68, 69) 
There was low quality evidence from three trials (n=214) that individual psychological 
interventions might be associated with a reduction in hospitalisations, but the confidence 
interval was compatible with both a reduction and an increase in the effect.(34, 64, 68, 69)  
 
Group psychological interventions 
The search identified 12 RCTs (n=914) of group interventions including 
psychoeducation,(49, 70-73) cognitive behavioural therapy,(32, 74, 75) mindfulness therapy, 
(76, 77) social cognition and interaction training,(78) and dialectical behaviour therapy.(44) 
Interventions were compared with treatment as usual except for two studies that compared 
psychoeducation with attention control.(70, 71) In ten trials participants were euthymic at 
baseline(32, 70-78), one study included participants experiencing an acute episode of mania 
or depression (49) and another included people who were currently depressed.  
Eight trials (n= 423) reported very low quality evidence of a small effect on depression 
outcomes at post-treatment favouring group interventions.(32, 44, 49, 73, 75-78) Six trials 
(n=375) found no effect on manic symptoms.(32, 49, 73, 75, 76, 78) Furthermore, the two 
studies comparing psychoeducation to attention control (n=170) found low quality evidence 
for a reduction in any type of relapse, but the confidence interval was compatible with both a 
reduction and increase in the effect.(70, 71) The two studies did find evidence for a reduction 
in depressive and manic relapses. Also, the two studies together with a trial comparing CBT 
with treatment as usual (n=205) reported low quality evidence that group interventions might 
be associated with a reduction in hospitalisations, but the confidence interval was compatible 
with both a reduction and increase in the effect.(70, 71, 75) 
Results at follow-up in five studies (n=333) reported low quality evidence of a reduction 
in depressive relapses.(70, 71, 73, 74, 76) Also, four studies (n=274) reported a reduction of 
relapses into mixed episodes.(70, 71, 73, 74) However, effects on depressive symptoms(32, 
73, 76) and hospitalisation(70, 71) were inconclusive.  
 
Family psychoeducation 
The search identified seven RCTs (n=409) of family psychoeducation. Two trials included 
psychoeducation for participants and their family members(50, 79) and in five trials only 
family members received psychoeducation.(57, 80-83) Interventions were compared with 
treatment as usual. Five trials enrolled participants who were euthymic at baseline, one trial 
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enrolled participants who were experiencing acute episode of mania or depression or were 
euthymic at baseline(57) and another included only participants who were in an acute episode 
of mania or depression.(50) 
One trial (n=43) found low quality evidence of medium effect in reduction of depressive 
and manic symptoms favouring family psychoeducation at post-treatment.(57)   
At follow-up, three trials (n=228) reported low quality evidence of a reduction in 
relapse.(79, 80, 82)  One trial (n=113) reported a reduction in manic relapses.(82) One study 
(n=57) reported a very large effect on reduction of the number of hospitalisation, but there 
were only nine events in the study.(80)  
 
Collaborative care  
The search identified five RCTs (n=1058) on collaborative care compared with treatment 
as usual. Two trials on collaborative care started with euthymic participants,(47, 84) three 
trials recruited participants in an episode.(53-55)   
In comparison to treatment as usual, two trials (n=123) reported low quality evidence of 
small effect favouring collaborative care on depressive symptoms and no effect on manic 
symptoms at post-treatment, but the effect estimates were imprecise.(53, 54) One trial 
(n=234) found no difference in reduction of relapses.(55) However, two trials (n=572) 
reported moderate quality evidence suggesting collaborative care reduced the number of 
hospitalisations at post-treatment.(55, 84)  
 
Integrated Cognitive and Interpersonal Therapy 
The search identified one RCT (n=212) with a group of participants that were randomised 
to integrated cognitive and interpersonal therapy or treatment as usual.(33) Participants in the 
intervention group could choose to follow individual or group integrated cognitive and 
interpersonal therapy. Outcome data were presented for the whole intervention group versus 
treatment as usual. 
The trial reported low quality evidence at post-treatment of a medium effect favouring the 
intervention on depressive symptoms and no effect on manic symptoms.  
 
Family-focused therapy  
The search identified four RCTs (n=357) on family focused therapy compared with 
psychoeducation, collaborative therapy or treatment as usual. Participants who were either 
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euthymic,(85) in an episode or euthymic,(56) only depressed(43), or in any type of 
episode.(50)     
Post-treatment data were of low quality. One study (n=79) found no effect of family 
focused therapy compared with treatment as usual on manic symptoms and a medium effect 
on depressive symptoms (although the confidence interval was also compatible with no 
effect).(56) A small effect was found on relapse in a study(n=53) comparing family focused 
therapy with psychoeducation, but the confidence interval was compatible with both a 
reduction and increase in the effect.(85) The confidence in the follow-up results were very 
low.  
 
Cognitive behavioural therapy versus supportive therapy 
The search identified one RCT (n=76) comparing individual cognitive behavioural therapy 
with supportive therapy, the quality of the evidence was low.(86) At post-treatment a medium 
effect was found of supportive therapy on depressive symptoms. Also a small effect was 
found of supportive therapy on manic symptoms, but cognitive behavioural therapy reduced 
the risk of relapses. However, the confidence intervals for the mania and relapse outcomes 
were compatible with either a reduction or increase in the true effect. 
 
Interpersonal and social rhythm therapy (IPSRT) versus (active) control  
The search identified three RCTs (n=299) of interpersonal and social rhythm therapy 
(IPSRT) compared with quetiapine, intensive clinical management or treatment as usual. 
Participants in all three trials were in a depressive episode at baseline.(43, 45, 48)  
One study reported a small effect of quetiapine compared to interpersonal and social 
rhythm therapy on symptoms of depression at post treatment, but the confidence interval was 
compatible with both a reduction and increase in the effect.(45) A trial (n=41) of 123 weeks 
found effects that were in favour of intensive clinical management compared to interpersonal 
and social rhythm therapy on a reduction in relapses, but the confidence interval was 
compatible with both a reduction and increase in the effect.(48) All results were of very low 
quality. 
 
Integrated group therapy versus group drug counselling 
The search identified one RCT (n=61) including people with both bipolar disorder and a 
comorbid substance abuse disorder who were either euthymic or acutely depressed at 
baseline.  It compared integrated group therapy with group drug counselling.(58) At post-
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treatment there was very low quality evidence of a small effect on depressive and manic 
symptoms, but confidence intervals were compatible with either reductions or increases in 




This is the first comprehensive systematic review and meta-analysis of the full range 
of psychological interventions that have been evaluated for the treatment of people with 
bipolar disorder. The evidence suggests that some, but not all, psychological treatments 
reduce relapse rates and hospitalisation, and they may improve depressive symptoms. In 
particular, we found moderate quality evidence that individual psychological interventions 
are associated with a 34% reduction in the risk of relapse at the end of treatment, sustained at 
26% reduction in risk at follow-up. There was also low quality evidence that individual 
psychological treatment reduced symptoms of depression, but the reduction may be small. 
Although the evidence is not as robust, group psycho-education also shows beneficial effects 
for reducing risk of relapse, and perhaps for some symptomatic improvement. We also found 
a substantial reduction in relapse rates for people who received family psycho-education, 
although the quality of the evidence for this finding was also low. In addition, our analysis of 
collaborative care shows moderate quality evidence for a 32% reduction in hospitalisation. 
We found little impact on symptoms of mania, quality of life, psychological functioning or 
other treatment outcomes, although in most cases the underpinning evidence was very low 
quality and therefore inconclusive. Moreover, we found no evidence of benefit for other types 
of psychological interventions such as interpersonal and social rhythm therapy.  
These results confirm and extend the findings of previous, smaller and narrower 
reviews of specific psychological treatments for bipolar disorder;(14, 15, 17-19) and suggest 
that, as the size of the evidence base has increased, the beneficial effects of some 
psychological interventions have become more apparent. Previous reviews included 10 or 
fewer trials and fewer than 1000 participants; by contrast, this review analysed 55 trials 
including data from 6010 participants. Overall, on the basis of this review, we would 
recommend the use of psychological interventions in the treatment of people with bipolar 
disorder to reduce relapse rates and to reduce depressive symptoms. Although there is not 
sufficient evidence to recommend a specific treatment over the others, the best evidence is for 
individual structured psychological interventions, and there is weaker, but still promising, 
evidence for group and family interventions, and for collaborative care. 
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These results are consistent with other recent reviews showing that psychological 
approaches may reduce transition to psychosis, including for people with bipolar 
disorder,(87) and that family psychological interventions reduce relapse rates in people with 
early(88) and established schizophrenia.(89) Additionally, psychological interventions are the 
most effective interventions for people with major depression.(90) The effectiveness of 
psychological interventions in these closely related conditions is promising for the 
psychological treatment of bipolar disorder, and effective psychological strategies for people 
with bipolar disorder could be clinically and economically important. 
 
Strengths and limitations  
Participants in our review are similar to those in ‘real world’ practice in several ways.  
For example, the proportion of men and women, and of people with bipolar type 1 and 
bipolar type 2 in the included studies were comparable to epidemiological samples.(4, 5) 
Most studies recruited participants from outpatient or community type setting, where these 
psychological interventions could be carried out. Few studies were undertaken outside of 
Europe and North America, and the effects of psychological interventions might differ in 
places with different healthcare systems and different levels community support.  
Although the evidence provides support for the use of psychological interventions in 
the treatment of people with bipolar disorder, our meta-analysis includes a number of trials 
with participants in different phases, sometimes euthymic, sometimes depressive, sometimes 
a mixture of both, and sometimes a mixture of depressive and manic. Most of the trials with 
participants in different phases of the illness did not report disaggregated data for people in 
the euthymic and the depressive phases, or for people who were depressed and people who 
were manic at the start of the trial. This is likely to lead to underestimating the effects on 
symptoms; people who are euthymic are without symptoms, thereby diluting the mean impact 
of psychological intervention on depressive and manic symptoms in these mixed populations. 
Similarly, where data on relapse includes trials in which participants were manic, this may 
have led to underestimating the impact on relapse rates; people who are manic are often 
difficult to engage in any psychological treatment, thereby diluting the effects of 
psychological therapy on relapse rates for those who are euthymic or depressed. In addition, 
the lack of disaggregated data on outcomes for people with mania makes it impossible to 
identify any possible harms or benefits of psychological therapies for this group. Finally, a 
limitation of including participants at different phases of illness is that we are not comparing 
like with like. Although statistical heterogeneity was minimal, summary effects should be 
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interpreted with some caution in light of the clinical differences among participants across 
trials. 
A further potential limitation of this analysis is the quality of the data. In some 
comparisons, evidence for different outcomes was not consistent. For example, a 
psychological intervention may appear to reduce symptoms but have no effect on treatment 
response.  Some trials were not registered, and there was evidence of selective reporting of 
outcomes, which could lead us to overestimate the benefits of psychological treatments in 
much the same way as selective publishing of drug studies has led to overestimating their true 
effectiveness.(91) Using GRADE to evaluate the quality of evidence underpinning each 
outcome, we incorporated these limitations in our evaluation of the results and restricted our 
conclusions to outcomes based on low and moderate quality evidence; importantly, evidence 
for key outcomes—relapse rates and symptoms—was better than evidence for most 
secondary outcomes. 
Almost all reviewed psychotherapies were given as adjuncts to pharmacotherapy 
(monotherapy or combinations of various medications), and they were delivered in a variety 
of different treatment modalities and service settings. Co-interventions and details about 
service settings were incompletely described in many trials and could contribute to 
unobserved heterogeneity. In addition, while statistical heterogeneity was minimal and there 
is a consensus that psychological treatments for bipolar disorder share many common 
elements and strategies (e.g. coping strategies for mood changes), they nevertheless differ in 
complexity, the skill and training required, content and duration, even when they bear the 
same name (e.g. cognitive behavioural therapy or psycho-education).  These problems may 
be addressed in further research in this rapidly expanding field.  
 
Implications for practice  
On the basis of this review, individual psychological interventions should be offered 
(in addition to whatever pharmacological interventions people already receive) with the aim 
of reducing relapse rates for people with bipolar disorder who are depressed or euthymic and 
for improving symptoms in people who are depressed. Although the evidence was limited for 
many outcomes in this review, there is strong evidence for the effectiveness of psychological 
interventions for unipolar depression(90) adding some support to the view that bipolar 
depression may be treated effectively with psychological treatment. It is also worth 
considering family psychological interventions, not just because the trials show some 
promise, but also because the benefits of family interventions for psychosis (including 
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schizophrenia and bipolar disorder) suggest that relapse rates can be reduced for early 
psychosis(88) and later psychosis.(89) It seems likely, on the basis of this broader evidence as 
well as the evidence in this review, that family interventions could be beneficial for people 
with bipolar disorder and should be made available routinely to help reduce relapse rates.  
People with bipolar disorder may also benefit from group psycho-education and from 
collaborative care. It is important to keep in mind that people with bipolar disorder are often 
only partially adherent to pharmacotherapy, which may contribute to the recurrence of 
symptoms and to relapse.(92) Group or family psycho-educational interventions and 
collaborative care could help the people develop skills related to medication use, stress 
management, recognising early symptoms, and coping with symptoms. Such skills could  
reduce risk of relapse and improve response.  
Worldwide there are few people with training and experience of delivering specific 
psychological interventions for people with bipolar depression. However, there are many 
therapists providing evidence-based treatments for unipolar depression in primary care.  
Because the rationale and process of delivering CBT for unipolar and bipolar depression is 
very similar, it might be sensible for CBT therapists in primary care to provide individual 
CBT for people with bipolar depression if they have experience in managing people with 
bipolar disorder or are supervised by clinicians with that experience. Many of the skills 
learned through CBT for depression could also help people with bipolar disorder who are 
euthymic avoid relapse. In the long-term, service providers and educational institutions 
should endeavour to increase the number of therapists trained specifically in the treatment of 
bipolar depression and the prevention of bipolar relapse.   
 
Directions for future research 
While this review supports the use of individual psychological intervention for relapse 
reduction and symptom improvement, we do not have sufficient information to know the 
impact on functioning and quality of life, both key concerns for people with bipolar disorder. 
Further research should include sufficiently large populations to address these critical 
outcomes. The same is true for family interventions.  Longer follow-up is needed to establish 
how well the effects of all of these interventions endure. Further research is needed to 
understand how psychological interventions compare with each other at each phase of the 
illness.  
Future studies could be improved by reporting results separately for people in different 
phases of the disorder (who are at risk of different outcomes), better describing treatments 
16 
 
and comparators, pre-registering trials, completely and transparently reporting all outcomes 
measured, and standardising the use of outcome measurement. Moreover, including an 
economic (cost-benefit) analysis in trials, especially when there is a possible reduction in 
relapse, would add greatly to our understanding of what we can do to help people with 
bipolar disorder; comparing the cost-effectiveness of individual and group approaches would 
address common concerns about method of delivery.   
There is very little, if any, evidence about which psychological treatments could be 
beneficial for people with more severe forms of bipolar disorder. More research could 
address the treatment of people who have very frequent episodes, people who are most 
severely functionally disabled, and people with persisting inter-episode symptoms. People 
who are hospitalized because of manic symptoms usually receive pharmacotherapy and we 
have identified no trial that examines whether a psychological intervention would be 
beneficial during this phase of the illness. Following this review, further research can be 
developed on the basis of much stronger evidence than was available only a few years ago.  It 
is clear that psychological interventions now have an important place alongside medication 
treatments in the treatment of people with bipolar disorder, and future research will elucidate 
the most effective ways to deliver psychotherapy.  
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